{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:07:31Z","timestamp":1790996851376,"version":"4.1.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with acute lymphoblastic leukemia (ALL) are at increased risk of thrombotic and\/or bleeding events during early chemotherapy, especially when receiving asparaginase. D-dimer is a marker of fibrinolysis that has been associated with thrombotic risk in solid cancers and acute myeloid leukemia; however, to date, no ALL-based study has assessed D-dimer level and risk for thrombosis. We sought to examine D-dimer as a biomarker for risk of thrombosis or bleeding during ALL treatment in a retrospective cohort study at The University of Chicago. We identified 61 consecutive adult patients with ALL, gathering demographic characteristics, treatment regimens, initial biomarkers including D-dimer, and assessing occurrence of venous or arterial thrombosis and bleeding in the first 100 days after diagnosis (index). The 100-day cumulative incidence (95% confidence interval [CI]) of venous or arterial thrombosis in\u00a0patients with high D-dimer (\u22654 \u00b5g\/mL) was 52.9% (95% CI, 26.4-73.8) compared with 13.8% (95% CI, 5.5-25.7) in patients with low to moderate D-dimer (&amp;lt;4 \u00b5g\/mL), corresponding with a hazard ratio of 5.04 (95% CI, 1.79-14.22). When testing for potential confounders in a series of bivariate logistic regression models, the association between D-dimer and thrombosis remained after adjusting for body mass index, age, sex, asparaginase treatment, disseminated intravascular coagulation score, initial platelet level, and ALL phenotype. In conclusion, D-dimer levels at ALL diagnosis are associated with venous or arterial thrombosis at 100 days. Future studies should include D-dimer collated with other known risk factors to build a risk assessment model for thrombosis in\u00a0patients with newly diagnosed ALL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007699","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T20:22:40Z","timestamp":1655842960000},"page":"5146-5151","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"6","author":[{"given":"Daniela R.","family":"Anderson","sequence":"first","affiliation":[{"name":"1Internal Medicine and Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Section of Hematology\/Oncology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore G.","family":"Karrison","sequence":"additional","affiliation":[{"name":"3Biological Sciences, The University of Chicago, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-345X","authenticated-orcid":false,"given":"Avi","family":"Leader","sequence":"additional","affiliation":[{"name":"4Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; and"},{"name":"5Hematology Institute, Rabin Medical Center, Petah Tikva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"issue":"9","key":"2022090215234147500_B1","first-page":"2200","article-title":"Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation","volume":"61","author":"Freyer","year":"2020","journal-title":"Leuk\u00a0Lymphoma."},{"issue":"3","key":"2022090215234147500_B2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/leu.2012.290","article-title":"The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia","volume":"27","author":"Truelove","year":"2013","journal-title":"Leukemia."},{"issue":"4","key":"2022090215234147500_B3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","article-title":"The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols","volume":"152","author":"Grace","year":"2011","journal-title":"Br J Haematol."},{"issue":"17","key":"2022090215234147500_B4","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1182\/blood-2008-08-175745","article-title":"Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and\u00a0effect on survival","volume":"113","author":"Ku","year":"2009","journal-title":"Blood."},{"issue":"22","key":"2022090215234147500_B5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","article-title":"Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years","volume":"131","author":"Rank","year":"2018","journal-title":"Blood."},{"issue":"3","key":"2022090215234147500_B6","first-page":"328","article-title":"Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study","volume":"136","author":"Orvain","year":"2020","journal-title":"Blood."},{"issue":"14","key":"2022090215234147500_B7","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood."},{"issue":"11","key":"2022090215234147500_B8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ajh.24130","article-title":"Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: the GRAALL experience","volume":"90","author":"Couturier","year":"2015","journal-title":"Am J Hematol."},{"issue":"21","key":"2022090215234147500_B9","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V122.21.3915.3915","article-title":"The number of peg-asparaginase doses administered is a determinant of relapse risk in adult ALL\u00a0treated with a pediatric-like regimen","volume":"122","author":"Aldoss","year":"2013","journal-title":"Blood."},{"issue":"5","key":"2022090215234147500_B10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bjh.16695","article-title":"Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy","volume":"191","author":"Sibai","year":"2020","journal-title":"Br J Haematol."},{"key":"2022090215234147500_B11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood-2018-99-109902","article-title":"Single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia \u2013 a NOPHO ALL2008 Study","volume":"132","author":"Jarvis","year":"2018","journal-title":"Blood."},{"key":"2022090215234147500_B12","first-page":"CD013399","article-title":"Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia","volume":"10","author":"Rank","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"issue":"12","key":"2022090215234147500_B13","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood-2013-04-460147","article-title":"Biomarkers for prediction of venous thromboembolism in cancer","volume":"122","author":"Pabinger","year":"2013","journal-title":"Blood."},{"issue":"14","key":"2022090215234147500_B14","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood."},{"issue":"2","key":"2022090215234147500_B15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"issue":"5","key":"2022090215234147500_B16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost."},{"issue":"2","key":"2022090215234147500_B17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.thromres.2008.08.009","article-title":"Definition of major bleeding used by US anticoagulation clinics","volume":"124","author":"Seto","year":"2009","journal-title":"Thromb Res."},{"issue":"11","key":"2022090215234147500_B18","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"1","key":"2022090215234147500_B19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1378\/chest.07-1432","article-title":"Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry","volume":"133","author":"Mu\u00f1oz","year":"2008","journal-title":"Chest."},{"issue":"2","key":"2022090215234147500_B20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0039-3400303","article-title":"Development of a clinical prediction rule for venous thromboembolism in patients with acute leukemia","volume":"120","author":"Al-Ani","year":"2020","journal-title":"Thromb Haemost."},{"issue":"14","key":"2022090215234147500_B21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood-2016-08-734715","article-title":"Thrombosis in AML? Yes, but when to worry?","volume":"128","author":"Stone","year":"2016","journal-title":"Blood."},{"issue":"2","key":"2022090215234147500_B22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11239-017-1597-7","article-title":"The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia","volume":"45","author":"Grace","year":"2018","journal-title":"J Thromb Thrombolysis."},{"issue":"22","key":"2022090215234147500_B23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1182\/blood.V128.22.1453.1453","article-title":"Anticoagulation prophylaxis in asparaginase-based therapy in adults with acute lymphoblastic leukemia","volume":"128","author":"Sibai","year":"2016","journal-title":"Blood."},{"issue":"2","key":"2022090215234147500_B24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jth.14671","article-title":"The prevention and management of asparaginase-related venous thromboembolism in adults: guidance from the SSC on Hemostasis and Malignancy of the ISTH","volume":"18","author":"Zwicker","year":"2020","journal-title":"J Thromb Haemost."},{"issue":"20","key":"2022090215234147500_B25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.18.01977","article-title":"Treatment and long-term clinical outcomes of incidental pulmonary embolism in patients with cancer: An international prospective cohort study","volume":"37","author":"Kraaijpoel","year":"2019","journal-title":"J Clin Oncol."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/17\/5146\/1918233\/advancesadv2022007699.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/17\/5146\/1918233\/advancesadv2022007699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T15:25:52Z","timestamp":1662132352000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/17\/5146\/485651\/D-dimer-and-risk-for-thrombosis-in-adults-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":25,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,9,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007699","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}